Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...

NHS approves £1.65m gene therapy for sickle cell disease, offering a potential cure. A milestone for patients, especially in ...

Sickle cell disease (SCD) has been historically overlooked and underfunded. For years, people living with SCD have faced shorter lifespans, inequitable and fragmented care, and a lack of ...

(HealthDay News) — Adults with sickle cell anemia (SCA) and healthy controls with greater economic deprivation have older brain age, according to a study published online Jan. 17 in JAMA Network Open.

The CDC reports about 100,000 people in the United States are affected by Sickle cell disease, and more than 90% are non-Black or African American. One local organization is aiming to shed light on ...

Most with sickle cell don’t have that option. It’s a decision that is open to many more people with sickle cell now that NICE has given the go ahead for Exa-cel (Casgevy) treatment to be used ...

According to research studies and demographic surveys by the Union Ministry of Tribal Affairs and genetic researchers, sickle cell disease is widespread in many tribal groups of India, especially amon ...

Read about exa-cel being rolled out on the NHS, providing a 'functional cure' for some patients with severe sickle cell ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Oman implemented a voluntary premarital screening in 1999 to control genetic diseases and foster a healthy society. Come 2026 ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...